All lobbying filings

THE WASHINGTON TAX & PUBLIC POLICY GROUP

THE WASHINGTON TAX & PUBLIC POLICY GROUP filed a Q2 report for REGENERON PHARMACEUTICALS, INC. on July 8, 2026, reporting $30,000 in lobbying income.

Lobbying for REGENERON PHARMACEUTICALS, INC. · Biotechnology company.

All filings by THE WASHINGTON TAX & PUBLIC POLICY GROUP · Everything REGENERON PHARMACEUTICALS, INC. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 8, 2026

Income

$30,000

What the client paid this registrant for the period.

Client based in

New York

Official filing document

Lobbyists on this filing 2

GREGORY NICKERSON

Previously held: Tax Counsel, Ways and Means Committee; Staff Director, Ways and Means Select Revenue Measures Subcommittee
ZACHARY AUSTIN PRICE

Previously held: Staff assistant to Sen. Coats

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Lobbying activity 1

Taxation/Internal Revenue Code

Issues related to corporate and international taxation. Issues related to OECD Pillar 1 and Pillar 2 negotiations, agreements, implementation, and reporting related to the taxation of global income. Issues related to IRC sections 11, 951A, and 250.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.